![David Sherris](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
David Sherris
Fondateur chez Paloma Pharmaceuticals, Inc.
Postes actifs de David Sherris
Sociétés | Poste | Début | Fin |
---|---|---|---|
Paloma Pharmaceuticals, Inc.
![]() Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Directeur/Membre du Conseil | - | - |
Directeur Général | 01/01/2005 | - | |
Fondateur | 01/01/2005 | - | |
President | 01/01/2005 | - | |
Treasurer | - | - |
Historique de carrière de David Sherris
Anciens postes connus de David Sherris
Sociétés | Poste | Début | Fin |
---|---|---|---|
RestorGenex Corp.
![]() RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Directeur/Membre du Conseil | 01/04/2014 | 17/06/2015 |
Directeur Technique/Scientifique/R&D | 01/04/2014 | 08/01/2016 | |
VasculoMedics, Inc.
![]() VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | President | - | - |
Formation de David Sherris
University of Utah | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 5 |
Opérationnelle
Director/Board Member | 2 |
President | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 4 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 3 |
---|---|
RestorGenex Corp.
![]() RestorGenex Corp. Pharmaceuticals: MajorHealth Technology RestorGenex Corp. operates as a specialty biopharmaceutical company, which focuses on developing products for dermatology, ophthalmology, and oncology. It products includes novel PI3K/Akt/mTOR pathway inhibitor which has completed two Phase I clinical trials for age-related macular degeneration and is in preclinical development in oncology, specifically glioblastoma multiforme. The company current pipeline also includes a soft anti-androgen compound for the treatment of acne vulgaris. RestorGenex was founded on March 14, 2008 and is headquartered in Buffalo Grove, IL. | Health Technology |
Paloma Pharmaceuticals, Inc.
![]() Paloma Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Paloma Pharmaceuticals, Inc. manufactures pharmaceutical drugs and related products. The firm’s product Cialis which develops drugs for cancer, ocular diseases, arthritis, fibrotic diseases, antiviral, skin diseases and erectile dysfunction. The company is headquartered in Jamaica Plain, MA. | Health Technology |
VasculoMedics, Inc.
![]() VasculoMedics, Inc. BiotechnologyHealth Technology Part of CervoMed, Inc., VasculoMedics, Inc. is a company that produces and develops zinc finger transcription factors for medical use. The company is based in Jamaica Plain, MA. VasculoMedics was acquired by Stratus Media Group, Inc. on March 28, 2014 for $1.39 million. | Health Technology |
- Bourse
- Insiders
- David Sherris
- Expérience